Clinical Trials Browser

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06014580 2025-03-07

MADONNA

Active not recruiting

276 enrolled

Gynecologic

Endometrial Neoplasms

NCT06728631 2025-02-24

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Phase 2 Active not recruiting

22 enrolled

Head & Neck

Mouth Neoplasms

NCT05857397 2025-02-12

CONOR

Active not recruiting

64 enrolled

Gynecologic

Ovarian Neoplasms

NCT06008353 2024-12-19

EDUR-BRA

Active not recruiting

60 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT00877214 2024-08-22

MAINTAIN

Phase 3 Active not recruiting

1,272 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Phase 2 Active not recruiting

264 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03469674 2023-10-11

PORTEC-4a

Phase 3 Active not recruiting

550 enrolled

Gynecologic

Endometrial Neoplasms

NCT05730647 2023-02-16

GIM 23- POSTER

Active not recruiting

600 enrolled

Breast

Breast Neoplasms

NCT04024475 2022-06-08

Prostate Cancer Biobank

Active not recruiting

1,323 enrolled

Genitourinary

Prostatic Neoplasms

NCT02113384 2021-07-28

LARC-EX

Active not recruiting

231 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Rectal Neoplasms

Clinical Trials

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial

ANVIL

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

AMBASSADOR

RESCUE

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

LORD

RB SFCE 09

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

REGAL

SABR-COMET 10

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Tempus Priority Study: A Pan-tumor Observational Study

MADONNA

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

CONOR

EDUR-BRA

MAINTAIN

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

PORTEC-4a

GIM 23- POSTER

Prostate Cancer Biobank

LARC-EX